These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 8081299)

  • 1. Daily variation in plasma concentration of fencamfamine and striatal dopamine receptors in rats.
    Planeta CS; DeLucia R; Aizenstein ML; Oliveira GH
    Braz J Med Biol Res; 1994 Mar; 27(3):737-41. PubMed ID: 8081299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian time-dependent effects of fencamfamine on inhibition of dopamine uptake and release in rat striatal slices.
    DeLucia R; Planeta CS; Ferreira MP; Aizenstein ML; Scavone C
    Braz J Med Biol Res; 1997 May; 30(5):637-40. PubMed ID: 9283632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The behavioral sensitization induced by fencamfamine is not related to plasma drug levels.
    Planeta CS; DeLucia R; Aizenstein ML
    Braz J Med Biol Res; 1995 Jun; 28(6):667-70. PubMed ID: 8547850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and neurochemical effects of fencamfamine on rats: a chronobiologic approach.
    Planeta Cda S; Aizenstein ML; Scavone C; DeLucia R
    Chronobiol Int; 1989; 6(4):313-20. PubMed ID: 2483362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal dopamine receptor sensitivity after subchronic fencamfamine in the rat.
    Scavone C; De Lucia R; Bernardi MM; Aizenstein ML
    Eur J Pharmacol; 1985 May; 112(1):11-6. PubMed ID: 4040467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reinforcing properties of fencamfamine: involvement of dopamine and opioid receptors.
    Planeta Cda S; Aizenstein ML; DeLucia R
    Pharmacol Biochem Behav; 1995 Jan; 50(1):35-40. PubMed ID: 7700952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dopamine and serotonin receptor antagonists on fencamfamine-induced abolition of latent inhibition.
    de Aguiar CR; de Aguiar MJ; DeLucia R; Silva MT
    Eur J Pharmacol; 2013 Jan; 698(1-3):246-51. PubMed ID: 23123352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fencamfamine modulates sodium, potassium-ATPase through cyclic AMP and cyclic AMP-dependent protein kinase in rat striatum.
    Pinto Ferreira M; DeLucia R; Luiz Aizenstein M; Glezer I; Scavone C
    J Neural Transm (Vienna); 1998; 105(6-7):549-60. PubMed ID: 9826101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the mechanism which mediates the effects of long-term administration of fencamfamine in rats.
    Planeta CS; DeLucia R; Aizenstein ML; Scavone C
    Braz J Med Biol Res; 1989; 22(7):881-3. PubMed ID: 2576524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
    Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postsynaptic location of acrylamide-induced modulation of striatal 3H-spiroperidol binding.
    Hong JS; Tilson HA; Agrawal AK; Karoum F; Bondy SC
    Neurotoxicology; 1982 Jul; 3(1):108-12. PubMed ID: 6890181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal dopamine receptor supersensitivity after long-term haloperidol treatment of hypophysectomized rats.
    DeLucia R; Scavone C; Camillo MA
    Braz J Med Biol Res; 1989; 22(6):741-3. PubMed ID: 2620186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
    Hilakivi I; Rinne J; Marjamäki P
    Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
    Hruska RE
    J Neurosci Res; 1984; 12(4):571-81. PubMed ID: 6512888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR; Molinoff PB
    Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperprolactinemia induced by long-term domperidone treatment does not alter the sensitivity of striatal dopamine receptors.
    Scavone C; DeLucia R; Dos-Santos LF
    Braz J Med Biol Res; 1991; 24(6):591-4. PubMed ID: 1823276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated administration intensifies the reinforcing effect of fencamfamine in rats.
    DeLucia R; Planeta CS; Aizenstein ML; Scavone C
    Gen Pharmacol; 1997 Aug; 29(2):265-7. PubMed ID: 9251911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of single and repeated administration of bromocriptine on monoamine metabolism in rat brain and [3H]spiroperidol binding to striatal membranes.
    Muradas V; Bazan E; Gervas JJ; Mena MA; de Yebenes JG
    Mov Disord; 1986; 1(2):103-12. PubMed ID: 3504236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptor binding in rat striatum: ultradian rhythm and its modification by chronic imipramine.
    Naber D; Wirz-Justice A; Kafka MS; Wehr TA
    Psychopharmacology (Berl); 1980; 68(1):1-5. PubMed ID: 6771793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.